gemcabene has been researched along with bms201038 in 2 studies
| Studies (gemcabene) | Trials (gemcabene) | Recent Studies (post-2010) (gemcabene) | Studies (bms201038) | Trials (bms201038) | Recent Studies (post-2010) (bms201038) |
|---|---|---|---|---|---|
| 18 | 3 | 9 | 128 | 13 | 106 |
| Protein | Taxonomy | gemcabene (IC50) | bms201038 (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0008 | |
| Microsomal triglyceride transfer protein large subunit | Homo sapiens (human) | 0.0056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajufo, E; Rader, DJ | 1 |
| Hegele, RA; Tsimikas, S | 1 |
1 review(s) available for gemcabene and bms201038
| Article | Year |
|---|---|
New Therapeutic Approaches for Familial Hypercholesterolemia.
Topics: Angiopoietin-like Proteins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Benzimidazoles; Caproates; Cholesterol Ester Transfer Proteins; Dicarboxylic Acids; Fatty Acids; Genetic Therapy; Humans; Hyperlipoproteinemia Type II; Oligonucleotides; Receptors, LDL; RNA, Small Interfering; Treatment Outcome | 2018 |
1 other study(ies) available for gemcabene and bms201038
| Article | Year |
|---|---|
Lipid-Lowering Agents.
Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Benzimidazoles; Caproates; Cholesterol, HDL; Cholesterol, LDL; Diacylglycerol O-Acyltransferase; Dicarboxylic Acids; Dyslipidemias; Ezetimibe; Fatty Acids; Genetic Therapy; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoprotein(a); Oligonucleotides; RNA, Small Interfering | 2019 |